FDG-PET Response-adapted Therapy Is 18F-Fluorodeoxyglucose Positron Emission Tomography a Safe Predictor for a Change of Therapy?

被引:8
|
作者
Hutchings, Martin [1 ]
机构
[1] Rigshosp, Dept Haematol, DK-2100 Copenhagen, Denmark
关键词
FDG-PET; PET/CT; Interim; Hodgkin; Lymphoma; Response adapted; UNFAVORABLE HODGKINS LYMPHOMA; CLINICAL-PRACTICE GUIDELINES; INVOLVED-FIELD RADIOTHERAPY; STEM-CELL TRANSPLANTATION; EVENT-FREE SURVIVAL; F-18-FDG PET; INTERIM-PET; CYCLES; INTERNATIONAL WORKSHOP; FINAL ANALYSIS;
D O I
10.1016/j.hoc.2013.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is the most accurate tool for staging, treatment monitoring, and response evaluation in Hodgkin lymphoma (HL). Early determination of treatment sensitivity by FDG-PET is the best tool to guide individualized, response-adapted treatment. Several ongoing or recently completed trials have investigated the use of FDG-PET/CT for early response-adapted HL therapy. The results are encouraging, but the data are immature, and PET response-adapted HL therapy is discouraged outside the setting of clinical trials. PET/CT looks promising for selection of therapy in relapsed and refractory disease, but the role in this setting is still unclear.
引用
收藏
页码:87 / +
页数:18
相关论文
共 50 条
  • [21] Lymphomatous involvement of the gastrointestinal tract:: Evaluation by positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG).
    Phongkitkarun, S
    Varavithya, V
    Kazama, T
    Faria, SC
    Mar, M
    Podoloff, DA
    Macapinlac, HA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 83P
  • [22] Timing of response evaluation with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant pleural mesothelioma (MPM): "Early'' versus "late'' assessment
    Ceresoli, Giovanni L.
    Zucali, Paolo A.
    Rodari, Marcello
    De Vincenzo, Fabio
    Salamina, Silvia
    Campagnoli, Elisabetta
    Garassino, Isabella
    Lutman, Romano F.
    Chiti, Arturo
    Santoro, Armando
    ANNALS OF ONCOLOGY, 2006, 17 : 267 - 267
  • [23] Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease
    Drzezga, Alexander
    Altomare, Daniele
    Festari, Cristina
    Arbizu, Javier
    Orini, Stefania
    Herholz, Karl
    Nestor, Peter
    Agosta, Federica
    Bouwman, Femke
    Nobili, Flavio
    Walker, Zuzana
    Frisoni, Giovanni Battista
    Boccardi, Marina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (09) : 1487 - 1496
  • [24] Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
    Alexander Drzezga
    Daniele Altomare
    Cristina Festari
    Javier Arbizu
    Stefania Orini
    Karl Herholz
    Peter Nestor
    Federica Agosta
    Femke Bouwman
    Flavio Nobili
    Zuzana Walker
    Giovanni Battista Frisoni
    Marina Boccardi
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1487 - 1496
  • [25] Exercise induced changes in whole-body energy metabolism evaluated by positron emission tomography and 18F-fluorodeoxyglucose (FDG-PET).
    Masud, MM
    Itoh, M
    Fujimoto, T
    Yamaguchi, K
    Saginoya, T
    Chida, Y
    Watanuki, S
    Miyake, M
    Targino, SR
    Sabina, K
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 343P - 343P
  • [26] Early restaging positron emission tomography with 18F-fluorodeoxyglucose (FDG PET) predicts response in patients with Hodgkin's disease
    Tani, M
    Fanti, S
    Stefoni, V
    Alinari, L
    Castellucci, P
    Marchi, E
    Gabriele, A
    Musuraca, G
    Farsad, M
    Fina, M
    Pileri, S
    Baccarani, M
    Zinzani, PL
    ANNALS OF ONCOLOGY, 2005, 16 : 146 - 146
  • [27] Positron emission tomography (PET) and [F-18]-fluorodeoxyglucose (FDG) in cancerology
    Maublant, J
    Vuillez, JP
    Talbot, JN
    Lumbroso, J
    Muratet, JP
    Herry, JY
    Artus, JC
    BULLETIN DU CANCER, 1998, 85 (11) : 935 - 950
  • [28] Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
    Andrea d’Amico
    La radiologia medica, 2015, 120 : 345 - 351
  • [29] Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
    d'Amico, Andrea
    RADIOLOGIA MEDICA, 2015, 120 (04): : 345 - 351
  • [30] 18F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer
    Levy, Antonin
    Leboulleux, Sophie
    Lepoutre-Lussey, Charlotte
    Baudin, Eric
    Al Ghuzlan, Abir
    Hartl, Dana
    Deutsch, Eric
    Deandreis, Desiree
    Lumbroso, Jean
    Tao, Yungan
    Schlumberger, Martin
    Blanchard, Pierre
    ORAL ONCOLOGY, 2015, 51 (04) : 370 - 375